SI-BONE is a brand-new company record, and its full research profile isn't ready yet.
si-bone.comCrawled Oct 25, 2026
The company provides an update on operations during the pandemic for customers.
2020 Letter from SI-BONE President, Chief Executive Officer and Chairman, Jeffrey Dunn
The page lists career opportunities, pay, stock, benefits, and company culture at SI-BONE.
SI-BONE is pleased to offer reimbursement support for its trained physicians.
The page addresses whether insurance covers the iFuse procedure for patients and providers.
Medicare, Medicaid, and some commercial plans cover minimally invasive SI joint fusion, though prior authorization may be required.
I started to notice pain in my right hip in 2018. It was a sharp stabbing pain; it was like someone was stabbing me with a knife. I was afraid I would need a hip replacement.
On occasion, SI-BONE may provide Product Donations to Health Care Professionals (HCPs) for the benefit of Indigent Patients.
Information about applicant guidelines, including requirements and an overview of the application process.
SI-BONE may fund educational activities, including medical society conferences, to advance scientific knowledge and healthcare delivery.
Advancing the diagnostic understanding of the sacroiliac joint and minimally invasive surgery for certain causes of SI joint disorders.
A unique body of clinical evidence supports the use of SI-BONE’s technologies, including two randomized controlled trials and hundreds of peer-reviewed publications. SI-BONE has leveraged its leadership in minimally invasive SI joint fusion to commercialize novel solutions for adjacent markets.
SI-BONE develops the iFuse Implant System, a minimally invasive treatment for sacroiliac joint disorders.
We believe in iFuse and stand behind our medical devices 100%. Our warranty for iFuse medical providers proves it.
Terms of Use for SI-BONE, Inc.